Efficacy, drug sustainability, and safety of ustekinumab treatment in Crohn's disease patients over three years.
Barkai LJ, Gonczi L, Balogh F, Angyal D, Farkas K, Farkas B, Molnar T, Szamosi T, Schafer E, Golovics PA, Juhasz M, Patai A, Vincze A, Sarlos P, Farkas A, Dubravcsik Z, Toth TG, Szekely H, Miheller P, Lakatos PL, Ilias A.
Barkai LJ, et al. Among authors: golovics pa.
Sci Rep. 2024 Jun 28;14(1):14909. doi: 10.1038/s41598-024-65987-1.
Sci Rep. 2024.
PMID: 38942890
Free PMC article.